nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2C8—Tazarotene—psoriasis	0.0585	0.0859	CbGbCtD
Nicardipine—CYP3A5—Beclomethasone—psoriasis	0.0566	0.083	CbGbCtD
Nicardipine—CYP2B6—Cholecalciferol—psoriasis	0.033	0.0484	CbGbCtD
Nicardipine—CYP2D6—Hydroxyurea—psoriasis	0.0263	0.0386	CbGbCtD
Nicardipine—CYP2C8—Cholecalciferol—psoriasis	0.025	0.0367	CbGbCtD
Nicardipine—CYP3A5—Mycophenolate mofetil—psoriasis	0.0225	0.0331	CbGbCtD
Nicardipine—CYP2C8—Mycophenolate mofetil—psoriasis	0.0217	0.0318	CbGbCtD
Nicardipine—CYP2C19—Cholecalciferol—psoriasis	0.021	0.0308	CbGbCtD
Nicardipine—CYP3A4—Calcitriol—psoriasis	0.0197	0.0289	CbGbCtD
Nicardipine—CYP3A5—Hydrocortisone—psoriasis	0.0181	0.0265	CbGbCtD
Nicardipine—CYP2C9—Cholecalciferol—psoriasis	0.0174	0.0256	CbGbCtD
Nicardipine—CYP2C8—Hydrocortisone—psoriasis	0.0174	0.0255	CbGbCtD
Nicardipine—CYP3A5—Cyclosporine—psoriasis	0.0171	0.0251	CbGbCtD
Nicardipine—CYP2C8—Cyclosporine—psoriasis	0.0164	0.0241	CbGbCtD
Nicardipine—CYP2D6—Cholecalciferol—psoriasis	0.0159	0.0234	CbGbCtD
Nicardipine—CYP3A4—Methoxsalen—psoriasis	0.0153	0.0224	CbGbCtD
Nicardipine—ABCB1—Mycophenolate mofetil—psoriasis	0.0147	0.0215	CbGbCtD
Nicardipine—CYP2C19—Prednisone—psoriasis	0.0145	0.0213	CbGbCtD
Nicardipine—CYP2E1—Dexamethasone—psoriasis	0.0145	0.0212	CbGbCtD
Nicardipine—CYP2B6—Dexamethasone—psoriasis	0.0143	0.0209	CbGbCtD
Nicardipine—CYP2C19—Cyclosporine—psoriasis	0.0138	0.0202	CbGbCtD
Nicardipine—ABCB1—Betamethasone—psoriasis	0.0126	0.0185	CbGbCtD
Nicardipine—ABCB1—Prednisolone—psoriasis	0.0124	0.0182	CbGbCtD
Nicardipine—ABCB1—Hydrocortisone—psoriasis	0.0118	0.0173	CbGbCtD
Nicardipine—ABCB1—Prednisone—psoriasis	0.0117	0.0172	CbGbCtD
Nicardipine—CYP2C9—Cyclosporine—psoriasis	0.0114	0.0168	CbGbCtD
Nicardipine—CYP3A5—Dexamethasone—psoriasis	0.0112	0.0165	CbGbCtD
Nicardipine—ABCB1—Cyclosporine—psoriasis	0.0111	0.0163	CbGbCtD
Nicardipine—CYP2C8—Dexamethasone—psoriasis	0.0108	0.0159	CbGbCtD
Nicardipine—CYP2D6—Cyclosporine—psoriasis	0.0105	0.0154	CbGbCtD
Nicardipine—CYP3A4—Cholecalciferol—psoriasis	0.0101	0.0149	CbGbCtD
Nicardipine—CYP2C19—Dexamethasone—psoriasis	0.00907	0.0133	CbGbCtD
Nicardipine—CYP3A4—Triamcinolone—psoriasis	0.00878	0.0129	CbGbCtD
Nicardipine—CYP3A4—Mycophenolate mofetil—psoriasis	0.00878	0.0129	CbGbCtD
Nicardipine—CYP2C9—Dexamethasone—psoriasis	0.00754	0.0111	CbGbCtD
Nicardipine—CYP3A4—Betamethasone—psoriasis	0.00753	0.0111	CbGbCtD
Nicardipine—CYP3A4—Prednisolone—psoriasis	0.00743	0.0109	CbGbCtD
Nicardipine—ABCB1—Dexamethasone—psoriasis	0.00732	0.0107	CbGbCtD
Nicardipine—CYP3A4—Hydrocortisone—psoriasis	0.00705	0.0103	CbGbCtD
Nicardipine—CYP3A4—Prednisone—psoriasis	0.00702	0.0103	CbGbCtD
Nicardipine—CYP2D6—Dexamethasone—psoriasis	0.00689	0.0101	CbGbCtD
Nicardipine—CYP3A4—Cyclosporine—psoriasis	0.00666	0.00977	CbGbCtD
Nicardipine—ABCB1—Methotrexate—psoriasis	0.00588	0.00863	CbGbCtD
Nicardipine—CYP3A4—Dexamethasone—psoriasis	0.00438	0.00643	CbGbCtD
Nicardipine—Erectile dysfunction—Methotrexate—psoriasis	0.000197	0.000947	CcSEcCtD
Nicardipine—Dyspnoea—Cyclosporine—psoriasis	0.000196	0.000943	CcSEcCtD
Nicardipine—Somnolence—Cyclosporine—psoriasis	0.000195	0.00094	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000195	0.00094	CcSEcCtD
Nicardipine—Oedema—Hydrocortisone—psoriasis	0.000195	0.00094	CcSEcCtD
Nicardipine—Tachycardia—Prednisolone—psoriasis	0.000195	0.000939	CcSEcCtD
Nicardipine—Asthenia—Mycophenolic acid—psoriasis	0.000195	0.000938	CcSEcCtD
Nicardipine—Hypertension—Triamcinolone—psoriasis	0.000194	0.000936	CcSEcCtD
Nicardipine—Infection—Hydrocortisone—psoriasis	0.000194	0.000934	CcSEcCtD
Nicardipine—Insomnia—Mycophenolate mofetil—psoriasis	0.000194	0.000933	CcSEcCtD
Nicardipine—Dyspepsia—Cyclosporine—psoriasis	0.000193	0.000931	CcSEcCtD
Nicardipine—Hyperhidrosis—Prednisolone—psoriasis	0.000193	0.00093	CcSEcCtD
Nicardipine—Nausea—Hydroxyurea—psoriasis	0.000193	0.000927	CcSEcCtD
Nicardipine—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000192	0.000926	CcSEcCtD
Nicardipine—Shock—Hydrocortisone—psoriasis	0.000192	0.000925	CcSEcCtD
Nicardipine—Myalgia—Triamcinolone—psoriasis	0.000192	0.000923	CcSEcCtD
Nicardipine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000191	0.00092	CcSEcCtD
Nicardipine—Tachycardia—Hydrocortisone—psoriasis	0.000191	0.000917	CcSEcCtD
Nicardipine—Somnolence—Mycophenolate mofetil—psoriasis	0.00019	0.000917	CcSEcCtD
Nicardipine—Flushing—Prednisone—psoriasis	0.00019	0.000914	CcSEcCtD
Nicardipine—Ill-defined disorder—Betamethasone—psoriasis	0.00019	0.000913	CcSEcCtD
Nicardipine—Ill-defined disorder—Dexamethasone—psoriasis	0.00019	0.000913	CcSEcCtD
Nicardipine—Discomfort—Triamcinolone—psoriasis	0.000189	0.000912	CcSEcCtD
Nicardipine—Hyperhidrosis—Hydrocortisone—psoriasis	0.000189	0.000909	CcSEcCtD
Nicardipine—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000189	0.000908	CcSEcCtD
Nicardipine—Pain—Cyclosporine—psoriasis	0.000188	0.000904	CcSEcCtD
Nicardipine—Constipation—Cyclosporine—psoriasis	0.000188	0.000904	CcSEcCtD
Nicardipine—Dry mouth—Triamcinolone—psoriasis	0.000188	0.000903	CcSEcCtD
Nicardipine—Diarrhoea—Mycophenolic acid—psoriasis	0.000186	0.000894	CcSEcCtD
Nicardipine—Conjunctivitis—Methotrexate—psoriasis	0.000185	0.000891	CcSEcCtD
Nicardipine—Malaise—Dexamethasone—psoriasis	0.000184	0.000887	CcSEcCtD
Nicardipine—Malaise—Betamethasone—psoriasis	0.000184	0.000887	CcSEcCtD
Nicardipine—Oedema—Triamcinolone—psoriasis	0.000184	0.000885	CcSEcCtD
Nicardipine—Vertigo—Dexamethasone—psoriasis	0.000184	0.000884	CcSEcCtD
Nicardipine—Vertigo—Betamethasone—psoriasis	0.000184	0.000884	CcSEcCtD
Nicardipine—Syncope—Betamethasone—psoriasis	0.000183	0.000882	CcSEcCtD
Nicardipine—Syncope—Dexamethasone—psoriasis	0.000183	0.000882	CcSEcCtD
Nicardipine—Constipation—Mycophenolate mofetil—psoriasis	0.000183	0.000882	CcSEcCtD
Nicardipine—Pain—Mycophenolate mofetil—psoriasis	0.000183	0.000882	CcSEcCtD
Nicardipine—Infection—Triamcinolone—psoriasis	0.000183	0.000879	CcSEcCtD
Nicardipine—Sweating—Methotrexate—psoriasis	0.000182	0.000879	CcSEcCtD
Nicardipine—Hypotension—Hydrocortisone—psoriasis	0.000182	0.000878	CcSEcCtD
Nicardipine—Haematuria—Methotrexate—psoriasis	0.000181	0.000874	CcSEcCtD
Nicardipine—Feeling abnormal—Cyclosporine—psoriasis	0.000181	0.000872	CcSEcCtD
Nicardipine—Shock—Triamcinolone—psoriasis	0.000181	0.000871	CcSEcCtD
Nicardipine—Insomnia—Prednisolone—psoriasis	0.000181	0.00087	CcSEcCtD
Nicardipine—Gastrointestinal pain—Cyclosporine—psoriasis	0.00018	0.000865	CcSEcCtD
Nicardipine—Loss of consciousness—Betamethasone—psoriasis	0.00018	0.000865	CcSEcCtD
Nicardipine—Loss of consciousness—Dexamethasone—psoriasis	0.00018	0.000865	CcSEcCtD
Nicardipine—Dizziness—Mycophenolic acid—psoriasis	0.00018	0.000865	CcSEcCtD
Nicardipine—Paraesthesia—Prednisolone—psoriasis	0.000179	0.000864	CcSEcCtD
Nicardipine—Tachycardia—Triamcinolone—psoriasis	0.000179	0.000864	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000178	0.000856	CcSEcCtD
Nicardipine—Hyperhidrosis—Triamcinolone—psoriasis	0.000178	0.000856	CcSEcCtD
Nicardipine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000177	0.00085	CcSEcCtD
Nicardipine—Insomnia—Hydrocortisone—psoriasis	0.000177	0.00085	CcSEcCtD
Nicardipine—Hypertension—Dexamethasone—psoriasis	0.000176	0.00085	CcSEcCtD
Nicardipine—Hypertension—Betamethasone—psoriasis	0.000176	0.00085	CcSEcCtD
Nicardipine—Paraesthesia—Hydrocortisone—psoriasis	0.000175	0.000844	CcSEcCtD
Nicardipine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000175	0.000844	CcSEcCtD
Nicardipine—Myalgia—Betamethasone—psoriasis	0.000174	0.000838	CcSEcCtD
Nicardipine—Myalgia—Dexamethasone—psoriasis	0.000174	0.000838	CcSEcCtD
Nicardipine—Body temperature increased—Cyclosporine—psoriasis	0.000174	0.000836	CcSEcCtD
Nicardipine—Abdominal pain—Cyclosporine—psoriasis	0.000174	0.000836	CcSEcCtD
Nicardipine—Anxiety—Dexamethasone—psoriasis	0.000173	0.000835	CcSEcCtD
Nicardipine—Anxiety—Betamethasone—psoriasis	0.000173	0.000835	CcSEcCtD
Nicardipine—Vomiting—Mycophenolic acid—psoriasis	0.000173	0.000831	CcSEcCtD
Nicardipine—Discomfort—Betamethasone—psoriasis	0.000172	0.000828	CcSEcCtD
Nicardipine—Discomfort—Dexamethasone—psoriasis	0.000172	0.000828	CcSEcCtD
Nicardipine—Dyspepsia—Hydrocortisone—psoriasis	0.000172	0.000827	CcSEcCtD
Nicardipine—Rash—Mycophenolic acid—psoriasis	0.000171	0.000824	CcSEcCtD
Nicardipine—Dermatitis—Mycophenolic acid—psoriasis	0.000171	0.000824	CcSEcCtD
Nicardipine—Pain—Prednisolone—psoriasis	0.000171	0.000823	CcSEcCtD
Nicardipine—Headache—Mycophenolic acid—psoriasis	0.00017	0.000819	CcSEcCtD
Nicardipine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000169	0.000816	CcSEcCtD
Nicardipine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000169	0.000816	CcSEcCtD
Nicardipine—Vision blurred—Prednisone—psoriasis	0.000168	0.000808	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000167	0.000806	CcSEcCtD
Nicardipine—Pain—Hydrocortisone—psoriasis	0.000167	0.000804	CcSEcCtD
Nicardipine—Oedema—Betamethasone—psoriasis	0.000167	0.000803	CcSEcCtD
Nicardipine—Oedema—Dexamethasone—psoriasis	0.000167	0.000803	CcSEcCtD
Nicardipine—Insomnia—Triamcinolone—psoriasis	0.000166	0.0008	CcSEcCtD
Nicardipine—Infection—Betamethasone—psoriasis	0.000166	0.000798	CcSEcCtD
Nicardipine—Infection—Dexamethasone—psoriasis	0.000166	0.000798	CcSEcCtD
Nicardipine—Ill-defined disorder—Prednisone—psoriasis	0.000165	0.000795	CcSEcCtD
Nicardipine—Paraesthesia—Triamcinolone—psoriasis	0.000165	0.000795	CcSEcCtD
Nicardipine—Feeling abnormal—Prednisolone—psoriasis	0.000165	0.000793	CcSEcCtD
Nicardipine—Visual impairment—Methotrexate—psoriasis	0.000165	0.000793	CcSEcCtD
Nicardipine—Shock—Dexamethasone—psoriasis	0.000164	0.00079	CcSEcCtD
Nicardipine—Shock—Betamethasone—psoriasis	0.000164	0.00079	CcSEcCtD
Nicardipine—Dyspnoea—Triamcinolone—psoriasis	0.000164	0.000789	CcSEcCtD
Nicardipine—Agitation—Prednisone—psoriasis	0.000164	0.000787	CcSEcCtD
Nicardipine—Thrombocytopenia—Dexamethasone—psoriasis	0.000163	0.000786	CcSEcCtD
Nicardipine—Thrombocytopenia—Betamethasone—psoriasis	0.000163	0.000786	CcSEcCtD
Nicardipine—Tachycardia—Dexamethasone—psoriasis	0.000163	0.000784	CcSEcCtD
Nicardipine—Tachycardia—Betamethasone—psoriasis	0.000163	0.000784	CcSEcCtD
Nicardipine—Hypersensitivity—Cyclosporine—psoriasis	0.000162	0.000779	CcSEcCtD
Nicardipine—Dyspepsia—Triamcinolone—psoriasis	0.000162	0.000779	CcSEcCtD
Nicardipine—Nausea—Mycophenolic acid—psoriasis	0.000161	0.000777	CcSEcCtD
Nicardipine—Hyperhidrosis—Dexamethasone—psoriasis	0.000161	0.000776	CcSEcCtD
Nicardipine—Hyperhidrosis—Betamethasone—psoriasis	0.000161	0.000776	CcSEcCtD
Nicardipine—Feeling abnormal—Hydrocortisone—psoriasis	0.000161	0.000775	CcSEcCtD
Nicardipine—Malaise—Prednisone—psoriasis	0.00016	0.000773	CcSEcCtD
Nicardipine—Vertigo—Prednisone—psoriasis	0.00016	0.00077	CcSEcCtD
Nicardipine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.00016	0.000769	CcSEcCtD
Nicardipine—Syncope—Prednisone—psoriasis	0.00016	0.000768	CcSEcCtD
Nicardipine—Tinnitus—Methotrexate—psoriasis	0.000159	0.000767	CcSEcCtD
Nicardipine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000158	0.00076	CcSEcCtD
Nicardipine—Asthenia—Cyclosporine—psoriasis	0.000158	0.000759	CcSEcCtD
Nicardipine—Pain—Triamcinolone—psoriasis	0.000157	0.000757	CcSEcCtD
Nicardipine—Loss of consciousness—Prednisone—psoriasis	0.000156	0.000753	CcSEcCtD
Nicardipine—Hypotension—Dexamethasone—psoriasis	0.000156	0.00075	CcSEcCtD
Nicardipine—Hypotension—Betamethasone—psoriasis	0.000156	0.00075	CcSEcCtD
Nicardipine—Abdominal pain—Hydrocortisone—psoriasis	0.000154	0.000743	CcSEcCtD
Nicardipine—Body temperature increased—Hydrocortisone—psoriasis	0.000154	0.000743	CcSEcCtD
Nicardipine—Asthenia—Mycophenolate mofetil—psoriasis	0.000154	0.00074	CcSEcCtD
Nicardipine—Hypertension—Prednisone—psoriasis	0.000154	0.00074	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000152	0.000732	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000152	0.000732	CcSEcCtD
Nicardipine—Arthralgia—Prednisone—psoriasis	0.000152	0.00073	CcSEcCtD
Nicardipine—Myalgia—Prednisone—psoriasis	0.000152	0.00073	CcSEcCtD
Nicardipine—Feeling abnormal—Triamcinolone—psoriasis	0.000151	0.000729	CcSEcCtD
Nicardipine—Anxiety—Prednisone—psoriasis	0.000151	0.000727	CcSEcCtD
Nicardipine—Insomnia—Betamethasone—psoriasis	0.000151	0.000726	CcSEcCtD
Nicardipine—Insomnia—Dexamethasone—psoriasis	0.000151	0.000726	CcSEcCtD
Nicardipine—Diarrhoea—Cyclosporine—psoriasis	0.00015	0.000724	CcSEcCtD
Nicardipine—Paraesthesia—Betamethasone—psoriasis	0.00015	0.000721	CcSEcCtD
Nicardipine—Paraesthesia—Dexamethasone—psoriasis	0.00015	0.000721	CcSEcCtD
Nicardipine—Discomfort—Prednisone—psoriasis	0.00015	0.000721	CcSEcCtD
Nicardipine—Hypersensitivity—Prednisolone—psoriasis	0.000147	0.000709	CcSEcCtD
Nicardipine—Dyspepsia—Betamethasone—psoriasis	0.000147	0.000707	CcSEcCtD
Nicardipine—Dyspepsia—Dexamethasone—psoriasis	0.000147	0.000707	CcSEcCtD
Nicardipine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000147	0.000706	CcSEcCtD
Nicardipine—Body temperature increased—Triamcinolone—psoriasis	0.000145	0.0007	CcSEcCtD
Nicardipine—Dizziness—Cyclosporine—psoriasis	0.000145	0.000699	CcSEcCtD
Nicardipine—Oedema—Prednisone—psoriasis	0.000145	0.000699	CcSEcCtD
Nicardipine—Infection—Prednisone—psoriasis	0.000144	0.000695	CcSEcCtD
Nicardipine—Hypersensitivity—Hydrocortisone—psoriasis	0.000144	0.000693	CcSEcCtD
Nicardipine—Shock—Prednisone—psoriasis	0.000143	0.000688	CcSEcCtD
Nicardipine—Pain—Betamethasone—psoriasis	0.000143	0.000687	CcSEcCtD
Nicardipine—Pain—Dexamethasone—psoriasis	0.000143	0.000687	CcSEcCtD
Nicardipine—Tachycardia—Prednisone—psoriasis	0.000142	0.000683	CcSEcCtD
Nicardipine—Dizziness—Mycophenolate mofetil—psoriasis	0.000142	0.000682	CcSEcCtD
Nicardipine—Hyperhidrosis—Prednisone—psoriasis	0.00014	0.000676	CcSEcCtD
Nicardipine—Vision blurred—Methotrexate—psoriasis	0.00014	0.000675	CcSEcCtD
Nicardipine—Asthenia—Hydrocortisone—psoriasis	0.00014	0.000674	CcSEcCtD
Nicardipine—Vomiting—Cyclosporine—psoriasis	0.00014	0.000672	CcSEcCtD
Nicardipine—Rash—Cyclosporine—psoriasis	0.000138	0.000667	CcSEcCtD
Nicardipine—Dermatitis—Cyclosporine—psoriasis	0.000138	0.000666	CcSEcCtD
Nicardipine—Ill-defined disorder—Methotrexate—psoriasis	0.000138	0.000664	CcSEcCtD
Nicardipine—Headache—Cyclosporine—psoriasis	0.000138	0.000663	CcSEcCtD
Nicardipine—Feeling abnormal—Betamethasone—psoriasis	0.000137	0.000662	CcSEcCtD
Nicardipine—Feeling abnormal—Dexamethasone—psoriasis	0.000137	0.000662	CcSEcCtD
Nicardipine—Gastrointestinal pain—Dexamethasone—psoriasis	0.000136	0.000657	CcSEcCtD
Nicardipine—Gastrointestinal pain—Betamethasone—psoriasis	0.000136	0.000657	CcSEcCtD
Nicardipine—Vomiting—Mycophenolate mofetil—psoriasis	0.000136	0.000656	CcSEcCtD
Nicardipine—Hypersensitivity—Triamcinolone—psoriasis	0.000135	0.000652	CcSEcCtD
Nicardipine—Rash—Mycophenolate mofetil—psoriasis	0.000135	0.000651	CcSEcCtD
Nicardipine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000135	0.00065	CcSEcCtD
Nicardipine—Headache—Mycophenolate mofetil—psoriasis	0.000134	0.000646	CcSEcCtD
Nicardipine—Malaise—Methotrexate—psoriasis	0.000134	0.000646	CcSEcCtD
Nicardipine—Vertigo—Methotrexate—psoriasis	0.000134	0.000643	CcSEcCtD
Nicardipine—Diarrhoea—Hydrocortisone—psoriasis	0.000134	0.000643	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Prednisone—psoriasis	0.000132	0.000637	CcSEcCtD
Nicardipine—Dizziness—Prednisolone—psoriasis	0.000132	0.000636	CcSEcCtD
Nicardipine—Asthenia—Triamcinolone—psoriasis	0.000132	0.000635	CcSEcCtD
Nicardipine—Abdominal pain—Dexamethasone—psoriasis	0.000132	0.000635	CcSEcCtD
Nicardipine—Abdominal pain—Betamethasone—psoriasis	0.000132	0.000635	CcSEcCtD
Nicardipine—Body temperature increased—Betamethasone—psoriasis	0.000132	0.000635	CcSEcCtD
Nicardipine—Body temperature increased—Dexamethasone—psoriasis	0.000132	0.000635	CcSEcCtD
Nicardipine—Insomnia—Prednisone—psoriasis	0.000131	0.000633	CcSEcCtD
Nicardipine—Nausea—Cyclosporine—psoriasis	0.00013	0.000628	CcSEcCtD
Nicardipine—Paraesthesia—Prednisone—psoriasis	0.00013	0.000628	CcSEcCtD
Nicardipine—Dizziness—Hydrocortisone—psoriasis	0.000129	0.000622	CcSEcCtD
Nicardipine—Dyspepsia—Prednisone—psoriasis	0.000128	0.000616	CcSEcCtD
Nicardipine—Nausea—Mycophenolate mofetil—psoriasis	0.000127	0.000613	CcSEcCtD
Nicardipine—Arthralgia—Methotrexate—psoriasis	0.000127	0.00061	CcSEcCtD
Nicardipine—Chest pain—Methotrexate—psoriasis	0.000127	0.00061	CcSEcCtD
Nicardipine—Myalgia—Methotrexate—psoriasis	0.000127	0.00061	CcSEcCtD
Nicardipine—Rash—Prednisolone—psoriasis	0.000126	0.000607	CcSEcCtD
Nicardipine—Dermatitis—Prednisolone—psoriasis	0.000126	0.000606	CcSEcCtD
Nicardipine—Headache—Prednisolone—psoriasis	0.000125	0.000603	CcSEcCtD
Nicardipine—Discomfort—Methotrexate—psoriasis	0.000125	0.000602	CcSEcCtD
Nicardipine—Constipation—Prednisone—psoriasis	0.000124	0.000598	CcSEcCtD
Nicardipine—Vomiting—Hydrocortisone—psoriasis	0.000124	0.000598	CcSEcCtD
Nicardipine—Rash—Hydrocortisone—psoriasis	0.000123	0.000593	CcSEcCtD
Nicardipine—Dermatitis—Hydrocortisone—psoriasis	0.000123	0.000592	CcSEcCtD
Nicardipine—Confusional state—Methotrexate—psoriasis	0.000122	0.000589	CcSEcCtD
Nicardipine—Headache—Hydrocortisone—psoriasis	0.000122	0.000589	CcSEcCtD
Nicardipine—Dizziness—Triamcinolone—psoriasis	0.000122	0.000585	CcSEcCtD
Nicardipine—Infection—Methotrexate—psoriasis	0.000121	0.000581	CcSEcCtD
Nicardipine—Feeling abnormal—Prednisone—psoriasis	0.00012	0.000576	CcSEcCtD
Nicardipine—Asthenia—Betamethasone—psoriasis	0.00012	0.000576	CcSEcCtD
Nicardipine—Asthenia—Dexamethasone—psoriasis	0.00012	0.000576	CcSEcCtD
Nicardipine—Thrombocytopenia—Methotrexate—psoriasis	0.000119	0.000572	CcSEcCtD
Nicardipine—Gastrointestinal pain—Prednisone—psoriasis	0.000119	0.000572	CcSEcCtD
Nicardipine—Nausea—Prednisolone—psoriasis	0.000119	0.000572	CcSEcCtD
Nicardipine—Hyperhidrosis—Methotrexate—psoriasis	0.000117	0.000565	CcSEcCtD
Nicardipine—Vomiting—Triamcinolone—psoriasis	0.000117	0.000563	CcSEcCtD
Nicardipine—Nausea—Hydrocortisone—psoriasis	0.000116	0.000558	CcSEcCtD
Nicardipine—Rash—Triamcinolone—psoriasis	0.000116	0.000558	CcSEcCtD
Nicardipine—Dermatitis—Triamcinolone—psoriasis	0.000116	0.000558	CcSEcCtD
Nicardipine—Headache—Triamcinolone—psoriasis	0.000115	0.000554	CcSEcCtD
Nicardipine—Body temperature increased—Prednisone—psoriasis	0.000115	0.000553	CcSEcCtD
Nicardipine—Abdominal pain—Prednisone—psoriasis	0.000115	0.000553	CcSEcCtD
Nicardipine—Diarrhoea—Betamethasone—psoriasis	0.000114	0.000549	CcSEcCtD
Nicardipine—Diarrhoea—Dexamethasone—psoriasis	0.000114	0.000549	CcSEcCtD
Nicardipine—Hypotension—Methotrexate—psoriasis	0.000113	0.000546	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000111	0.000532	CcSEcCtD
Nicardipine—Dizziness—Dexamethasone—psoriasis	0.00011	0.000531	CcSEcCtD
Nicardipine—Dizziness—Betamethasone—psoriasis	0.00011	0.000531	CcSEcCtD
Nicardipine—Insomnia—Methotrexate—psoriasis	0.00011	0.000529	CcSEcCtD
Nicardipine—Nausea—Triamcinolone—psoriasis	0.000109	0.000526	CcSEcCtD
Nicardipine—Paraesthesia—Methotrexate—psoriasis	0.000109	0.000525	CcSEcCtD
Nicardipine—Dyspnoea—Methotrexate—psoriasis	0.000108	0.000521	CcSEcCtD
Nicardipine—Somnolence—Methotrexate—psoriasis	0.000108	0.00052	CcSEcCtD
Nicardipine—Hypersensitivity—Prednisone—psoriasis	0.000107	0.000515	CcSEcCtD
Nicardipine—Dyspepsia—Methotrexate—psoriasis	0.000107	0.000514	CcSEcCtD
Nicardipine—Vomiting—Betamethasone—psoriasis	0.000106	0.000511	CcSEcCtD
Nicardipine—Vomiting—Dexamethasone—psoriasis	0.000106	0.000511	CcSEcCtD
Nicardipine—Rash—Betamethasone—psoriasis	0.000105	0.000506	CcSEcCtD
Nicardipine—Rash—Dexamethasone—psoriasis	0.000105	0.000506	CcSEcCtD
Nicardipine—Dermatitis—Dexamethasone—psoriasis	0.000105	0.000506	CcSEcCtD
Nicardipine—Dermatitis—Betamethasone—psoriasis	0.000105	0.000506	CcSEcCtD
Nicardipine—Headache—Betamethasone—psoriasis	0.000104	0.000503	CcSEcCtD
Nicardipine—Headache—Dexamethasone—psoriasis	0.000104	0.000503	CcSEcCtD
Nicardipine—Asthenia—Prednisone—psoriasis	0.000104	0.000502	CcSEcCtD
Nicardipine—Pain—Methotrexate—psoriasis	0.000104	0.0005	CcSEcCtD
Nicardipine—Feeling abnormal—Methotrexate—psoriasis	0.0001	0.000482	CcSEcCtD
Nicardipine—Diarrhoea—Prednisone—psoriasis	9.94e-05	0.000478	CcSEcCtD
Nicardipine—Gastrointestinal pain—Methotrexate—psoriasis	9.93e-05	0.000478	CcSEcCtD
Nicardipine—Nausea—Dexamethasone—psoriasis	9.91e-05	0.000477	CcSEcCtD
Nicardipine—Nausea—Betamethasone—psoriasis	9.91e-05	0.000477	CcSEcCtD
Nicardipine—Dizziness—Prednisone—psoriasis	9.6e-05	0.000462	CcSEcCtD
Nicardipine—Body temperature increased—Methotrexate—psoriasis	9.6e-05	0.000462	CcSEcCtD
Nicardipine—Abdominal pain—Methotrexate—psoriasis	9.6e-05	0.000462	CcSEcCtD
Nicardipine—Vomiting—Prednisone—psoriasis	9.23e-05	0.000445	CcSEcCtD
Nicardipine—Rash—Prednisone—psoriasis	9.16e-05	0.000441	CcSEcCtD
Nicardipine—Dermatitis—Prednisone—psoriasis	9.15e-05	0.000441	CcSEcCtD
Nicardipine—Headache—Prednisone—psoriasis	9.1e-05	0.000438	CcSEcCtD
Nicardipine—Hypersensitivity—Methotrexate—psoriasis	8.94e-05	0.000431	CcSEcCtD
Nicardipine—Asthenia—Methotrexate—psoriasis	8.71e-05	0.000419	CcSEcCtD
Nicardipine—Nausea—Prednisone—psoriasis	8.63e-05	0.000415	CcSEcCtD
Nicardipine—Diarrhoea—Methotrexate—psoriasis	8.31e-05	0.0004	CcSEcCtD
Nicardipine—Dizziness—Methotrexate—psoriasis	8.03e-05	0.000386	CcSEcCtD
Nicardipine—Vomiting—Methotrexate—psoriasis	7.72e-05	0.000372	CcSEcCtD
Nicardipine—Rash—Methotrexate—psoriasis	7.65e-05	0.000369	CcSEcCtD
Nicardipine—Dermatitis—Methotrexate—psoriasis	7.65e-05	0.000368	CcSEcCtD
Nicardipine—Headache—Methotrexate—psoriasis	7.6e-05	0.000366	CcSEcCtD
Nicardipine—Nausea—Methotrexate—psoriasis	7.21e-05	0.000347	CcSEcCtD
Nicardipine—CALM2—Innate Immune System—NFKB1—psoriasis	1.22e-05	0.00011	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—TYK2—psoriasis	1.22e-05	0.00011	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—NFKB1—psoriasis	1.21e-05	0.000109	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HLA-DRB1—psoriasis	1.21e-05	0.000109	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—NFKB1—psoriasis	1.2e-05	0.000108	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—CXCL8—psoriasis	1.19e-05	0.000107	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—NFKBIA—psoriasis	1.19e-05	0.000107	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—CAT—psoriasis	1.19e-05	0.000107	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—CAT—psoriasis	1.19e-05	0.000107	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—VEGFA—psoriasis	1.19e-05	0.000107	CbGpPWpGaD
Nicardipine—CHRM1—GPCR downstream signaling—CXCL8—psoriasis	1.19e-05	0.000107	CbGpPWpGaD
Nicardipine—CALM2—Disease—HLA-A—psoriasis	1.18e-05	0.000106	CbGpPWpGaD
Nicardipine—CALM1—Disease—HLA-A—psoriasis	1.18e-05	0.000106	CbGpPWpGaD
Nicardipine—CHRM3—GPCR downstream signaling—CXCL8—psoriasis	1.18e-05	0.000106	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—STAT3—psoriasis	1.18e-05	0.000106	CbGpPWpGaD
Nicardipine—PDE1A—Disease—IL6—psoriasis	1.17e-05	0.000106	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—NFKB1—psoriasis	1.17e-05	0.000106	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—NFKB1—psoriasis	1.17e-05	0.000106	CbGpPWpGaD
Nicardipine—CHRM2—GPCR downstream signaling—CXCL8—psoriasis	1.17e-05	0.000105	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HLA-DRB1—psoriasis	1.17e-05	0.000105	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HLA-DRB1—psoriasis	1.17e-05	0.000105	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	1.17e-05	0.000105	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—IL6—psoriasis	1.16e-05	0.000105	CbGpPWpGaD
Nicardipine—CALM3—Immune System—ICAM1—psoriasis	1.16e-05	0.000105	CbGpPWpGaD
Nicardipine—CALM3—Immune System—NFKBIA—psoriasis	1.15e-05	0.000104	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—APOE—psoriasis	1.14e-05	0.000103	CbGpPWpGaD
Nicardipine—CALM3—Disease—APOE—psoriasis	1.14e-05	0.000103	CbGpPWpGaD
Nicardipine—CALM2—Immune System—ICAM1—psoriasis	1.12e-05	0.000101	CbGpPWpGaD
Nicardipine—CALM1—Immune System—ICAM1—psoriasis	1.12e-05	0.000101	CbGpPWpGaD
Nicardipine—CALM2—Immune System—NFKBIA—psoriasis	1.11e-05	0.0001	CbGpPWpGaD
Nicardipine—CALM1—Immune System—NFKBIA—psoriasis	1.11e-05	0.0001	CbGpPWpGaD
Nicardipine—CALM2—Disease—APOE—psoriasis	1.1e-05	9.94e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—APOE—psoriasis	1.1e-05	9.94e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—VEGFA—psoriasis	1.09e-05	9.79e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TYK2—psoriasis	1.08e-05	9.76e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—SOCS1—psoriasis	1.08e-05	9.75e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—STAT3—psoriasis	1.08e-05	9.7e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—CXCL8—psoriasis	1.08e-05	9.7e-05	CbGpPWpGaD
Nicardipine—PDE1B—Disease—IL6—psoriasis	1.07e-05	9.67e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—CXCL8—psoriasis	1.07e-05	9.67e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—CAT—psoriasis	1.07e-05	9.63e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—NOS2—psoriasis	1.06e-05	9.57e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—CXCL8—psoriasis	1.06e-05	9.57e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—APOE—psoriasis	1.06e-05	9.55e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—LEP—psoriasis	1.06e-05	9.55e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	1.06e-05	9.55e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—SOCS1—psoriasis	1.05e-05	9.43e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—SOCS1—psoriasis	1.05e-05	9.43e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TYK2—psoriasis	1.04e-05	9.34e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—TYK2—psoriasis	1.03e-05	9.29e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—NOS2—psoriasis	1.03e-05	9.26e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—NOS2—psoriasis	1.03e-05	9.26e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—TYK2—psoriasis	9.98e-06	8.99e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—TYK2—psoriasis	9.98e-06	8.99e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PPARG—psoriasis	9.93e-06	8.95e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—NFKBIA—psoriasis	9.88e-06	8.9e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—APOE—psoriasis	9.81e-06	8.84e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TYK2—psoriasis	9.75e-06	8.78e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—APOE—psoriasis	9.61e-06	8.66e-05	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—TP53—psoriasis	9.6e-06	8.65e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—APOE—psoriasis	9.59e-06	8.64e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—LEP—psoriasis	9.57e-06	8.62e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—APOE—psoriasis	9.57e-06	8.62e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—APOE—psoriasis	9.55e-06	8.6e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—CAT—psoriasis	9.54e-06	8.6e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—APOE—psoriasis	9.54e-06	8.59e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—LEP—psoriasis	9.54e-06	8.59e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—LEP—psoriasis	9.44e-06	8.51e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—APOE—psoriasis	9.44e-06	8.51e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—CXCL8—psoriasis	9.43e-06	8.5e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—TYK2—psoriasis	9.42e-06	8.49e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—APOE—psoriasis	9.42e-06	8.49e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—LEP—psoriasis	9.42e-06	8.49e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CARM1—psoriasis	9.33e-06	8.41e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—CAT—psoriasis	9.31e-06	8.39e-05	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—TP53—psoriasis	9.29e-06	8.37e-05	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—TP53—psoriasis	9.29e-06	8.37e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—APOE—psoriasis	9.24e-06	8.32e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—APOE—psoriasis	9.24e-06	8.32e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—TYK2—psoriasis	9.12e-06	8.21e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—TYK2—psoriasis	9.12e-06	8.21e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—CXCL8—psoriasis	9.03e-06	8.14e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—CXCL8—psoriasis	8.98e-06	8.09e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—TP53—psoriasis	8.98e-06	8.09e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—IL6—psoriasis	8.96e-06	8.08e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—NFKBIA—psoriasis	8.91e-06	8.03e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—NFKBIA—psoriasis	8.89e-06	8.01e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IFNG—psoriasis	8.83e-06	7.95e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—NFKBIA—psoriasis	8.8e-06	7.93e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—CAT—psoriasis	8.78e-06	7.91e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	8.78e-06	7.91e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—JUN—psoriasis	8.76e-06	7.9e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—TYK2—psoriasis	8.7e-06	7.84e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—CAT—psoriasis	8.7e-06	7.84e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—CXCL8—psoriasis	8.69e-06	7.83e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—CXCL8—psoriasis	8.69e-06	7.83e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—IL6—psoriasis	8.59e-06	7.74e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PPARG—psoriasis	8.55e-06	7.7e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IFNG—psoriasis	8.54e-06	7.69e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IFNG—psoriasis	8.54e-06	7.69e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CD4—psoriasis	8.52e-06	7.68e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—CXCL8—psoriasis	8.49e-06	7.65e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—NFKB1—psoriasis	8.44e-06	7.6e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—TYK2—psoriasis	8.42e-06	7.58e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—TYK2—psoriasis	8.42e-06	7.58e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—JUN—psoriasis	8.39e-06	7.56e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PPARG—psoriasis	8.37e-06	7.54e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PPARG—psoriasis	8.35e-06	7.53e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PPARG—psoriasis	8.32e-06	7.49e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—APOE—psoriasis	8.31e-06	7.48e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CD4—psoriasis	8.25e-06	7.43e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CD4—psoriasis	8.25e-06	7.43e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—IL6—psoriasis	8.22e-06	7.41e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—TP53—psoriasis	8.21e-06	7.4e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TYK2—psoriasis	8.09e-06	7.29e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—NFKB1—psoriasis	8.08e-06	7.28e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—IL6—psoriasis	8.07e-06	7.27e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PPARG—psoriasis	8.04e-06	7.25e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PPARG—psoriasis	8.04e-06	7.25e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—LEP—psoriasis	7.98e-06	7.19e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—APOE—psoriasis	7.98e-06	7.19e-05	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—IL6—psoriasis	7.91e-06	7.13e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—JUN—psoriasis	7.89e-06	7.11e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—CD4—psoriasis	7.87e-06	7.09e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—APOE—psoriasis	7.72e-06	6.96e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—APOE—psoriasis	7.72e-06	6.96e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—LEP—psoriasis	7.72e-06	6.96e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—LEP—psoriasis	7.72e-06	6.96e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—VEGFA—psoriasis	7.66e-06	6.9e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—IL6—psoriasis	7.66e-06	6.9e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—IL6—psoriasis	7.66e-06	6.9e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—JUN—psoriasis	7.63e-06	6.87e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—CD4—psoriasis	7.61e-06	6.86e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—CD4—psoriasis	7.61e-06	6.86e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—NFKB1—psoriasis	7.6e-06	6.84e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—STAT3—psoriasis	7.58e-06	6.83e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—IL6—psoriasis	7.52e-06	6.77e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NFKBIA—psoriasis	7.44e-06	6.7e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—APOE—psoriasis	7.41e-06	6.68e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—JUN—psoriasis	7.38e-06	6.65e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—JUN—psoriasis	7.38e-06	6.65e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—NFKB1—psoriasis	7.34e-06	6.62e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—VEGFA—psoriasis	7.33e-06	6.61e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TYK2—psoriasis	7.3e-06	6.58e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TYK2—psoriasis	7.28e-06	6.56e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—STAT3—psoriasis	7.26e-06	6.54e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—APOE—psoriasis	7.24e-06	6.52e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PPARG—psoriasis	7.23e-06	6.52e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TYK2—psoriasis	7.21e-06	6.49e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NFKBIA—psoriasis	7.2e-06	6.48e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NFKBIA—psoriasis	7.2e-06	6.48e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TYK2—psoriasis	7.19e-06	6.48e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—NFKB1—psoriasis	7.1e-06	6.4e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—NFKB1—psoriasis	7.1e-06	6.4e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CXCL8—psoriasis	7.05e-06	6.35e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—VEGFA—psoriasis	6.89e-06	6.21e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—STAT3—psoriasis	6.83e-06	6.15e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—APOE—psoriasis	6.82e-06	6.14e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—APOE—psoriasis	6.76e-06	6.09e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—IL6—psoriasis	6.7e-06	6.04e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—STAT3—psoriasis	6.6e-06	5.95e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—JUN—psoriasis	6.55e-06	5.9e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PPARG—psoriasis	6.46e-06	5.82e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—STAT3—psoriasis	6.38e-06	5.75e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—STAT3—psoriasis	6.38e-06	5.75e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CXCL8—psoriasis	6.36e-06	5.73e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CXCL8—psoriasis	6.34e-06	5.71e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—NFKB1—psoriasis	6.3e-06	5.68e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PPARG—psoriasis	6.3e-06	5.68e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CXCL8—psoriasis	6.28e-06	5.65e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CXCL8—psoriasis	6.26e-06	5.64e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TYK2—psoriasis	6.09e-06	5.49e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—STAT3—psoriasis	6.09e-06	5.49e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—IL6—psoriasis	6.04e-06	5.45e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—IL6—psoriasis	6.03e-06	5.43e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—IL6—psoriasis	5.97e-06	5.38e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—IL6—psoriasis	5.95e-06	5.36e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PPARG—psoriasis	5.94e-06	5.35e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—JUN—psoriasis	5.91e-06	5.33e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TYK2—psoriasis	5.89e-06	5.31e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TYK2—psoriasis	5.89e-06	5.31e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—STAT3—psoriasis	5.89e-06	5.31e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—STAT3—psoriasis	5.89e-06	5.31e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—JUN—psoriasis	5.89e-06	5.31e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PPARG—psoriasis	5.89e-06	5.31e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—JUN—psoriasis	5.83e-06	5.26e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—JUN—psoriasis	5.82e-06	5.24e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TP53—psoriasis	5.79e-06	5.21e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CAT—psoriasis	5.74e-06	5.17e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—VEGFA—psoriasis	5.72e-06	5.16e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—NFKB1—psoriasis	5.69e-06	5.13e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—NFKB1—psoriasis	5.67e-06	5.11e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—STAT3—psoriasis	5.67e-06	5.11e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—NFKB1—psoriasis	5.62e-06	5.06e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—NFKB1—psoriasis	5.6e-06	5.05e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TP53—psoriasis	5.54e-06	4.99e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CXCL8—psoriasis	5.31e-06	4.78e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL6—psoriasis	5.3e-06	4.77e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—psoriasis	5.21e-06	4.69e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—VEGFA—psoriasis	5.16e-06	4.65e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—VEGFA—psoriasis	5.15e-06	4.64e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CXCL8—psoriasis	5.13e-06	4.62e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CXCL8—psoriasis	5.13e-06	4.62e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—STAT3—psoriasis	5.11e-06	4.61e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—VEGFA—psoriasis	5.1e-06	4.59e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—STAT3—psoriasis	5.1e-06	4.59e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—VEGFA—psoriasis	5.08e-06	4.58e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL6—psoriasis	5.07e-06	4.57e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—STAT3—psoriasis	5.05e-06	4.55e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL6—psoriasis	5.04e-06	4.55e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—STAT3—psoriasis	5.03e-06	4.53e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—JUN—psoriasis	4.93e-06	4.44e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL6—psoriasis	4.88e-06	4.4e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL6—psoriasis	4.88e-06	4.4e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—JUN—psoriasis	4.77e-06	4.3e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—JUN—psoriasis	4.77e-06	4.3e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL6—psoriasis	4.77e-06	4.3e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NFKB1—psoriasis	4.75e-06	4.28e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL6—psoriasis	4.61e-06	4.15e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NFKB1—psoriasis	4.59e-06	4.14e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NFKB1—psoriasis	4.59e-06	4.14e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL6—psoriasis	4.46e-06	4.02e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL6—psoriasis	4.46e-06	4.02e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—APOE—psoriasis	4.46e-06	4.02e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—psoriasis	4.32e-06	3.9e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VEGFA—psoriasis	4.31e-06	3.88e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—STAT3—psoriasis	4.27e-06	3.84e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—IL6—psoriasis	4.26e-06	3.83e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VEGFA—psoriasis	4.17e-06	3.76e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VEGFA—psoriasis	4.17e-06	3.76e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—STAT3—psoriasis	4.13e-06	3.72e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—STAT3—psoriasis	4.13e-06	3.72e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—IL6—psoriasis	4.12e-06	3.71e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—IL6—psoriasis	4.12e-06	3.71e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL6—psoriasis	3.96e-06	3.57e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—psoriasis	3.9e-06	3.52e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—psoriasis	3.89e-06	3.5e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PPARG—psoriasis	3.88e-06	3.5e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—psoriasis	3.85e-06	3.47e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—psoriasis	3.84e-06	3.46e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL6—psoriasis	3.57e-06	3.22e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL6—psoriasis	3.56e-06	3.21e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL6—psoriasis	3.53e-06	3.18e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL6—psoriasis	3.52e-06	3.17e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—psoriasis	3.26e-06	2.93e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—psoriasis	3.15e-06	2.84e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—psoriasis	3.15e-06	2.84e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL6—psoriasis	2.98e-06	2.69e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL6—psoriasis	2.88e-06	2.6e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL6—psoriasis	2.88e-06	2.6e-05	CbGpPWpGaD
